Interaction between glucose metabolism and endogenous insulin release in hypertension

Metabolism: Clinical and Experimental

Volumn 51, Issue 3, 2002, Pages 297-303

  Natalucci, Silvia ^a,b   Boemi, Massimo ^a,b   Fumelli, Daniele ^a,b   Fumelli, Paolo ^a,b   Burattini, Roberto ^a,b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b INRCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; C PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD SAMPLING; CELL STIMULATION; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPARTMENT MODEL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; KINETICS; MALE; MOLECULAR INTERACTION; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION;

EID: 0036121740     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2002.30503     Document Type: Article

References (27)

1. The association of hypertension, diabetes and obesity: A review
2. Hyperinsulinemia: A link between hypertension, obesity and glucose intolerance
3. Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension
4. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance
5. Impaired glucose tolerance in hypertension is associated with impaired insulin release independently of changes in insulin sensitivity
6. Insulin resistance versus insulin secretion in the hypertension of obesity
7. Insulin resistance in essential hypertension
8. Elevated hepatic insulin extraction in essential hypertension
9. One- and two-compartment minimal models detect similar alterations of glucose metabolism indexes in hypertension
10. Insulin resistance is a characteristic feature of primary hypertension independent of obesity
11. Resistance to insulin-stimulated-glucose uptake in patients with hypertension
12. Hypertension and insulin resistance: Role of sympathetic nervous system activity
13. Insulin secretion and hepatic insulin extraction in humans by minimal modeling of C-peptide and insulin kinetics
14. Estimation of β-cell sensitivity from intravenous glucose tolerance test C-peptide data
15. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance
16. Quantitative estimation of insulin sensitivity
17. Metabolic effects of isradipine versus hydrochlorothiazide in diabetes mellitus
18. Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension
19. SAAM II: Simulation, analysis, and modelling software for tracer and pharmacokinetics studies
20. Haemodynamic action of insulin
21. Effect of insulin on renal sodium excretion
22. Role of C-peptide kinetics in methods for assessing insulin secretion: Lesson from a new minimal model
23. Cardiovascular risk factors features of insulin resistance syndrome (Syndrome X) in a biracial (Black-White) population of children, adolescents, and young adults: The Bogalusa Heart Study
24. Minimal model overestimation and underestimation: Improved accuracy by a bayesian two compartment model
25. Hypertension and antihypertensive therapy as risk factor for type 2 diabetes mellitus. Atherosclerosis risk in Communities Study
26. Impaired insulin clearance in essential hypertension